Pages that link to "Q49561823"
Jump to navigation
Jump to search
The following pages link to Nicola Stefano Fracchiolla (Q49561823):
Displaying 50 items.
- Identification of a Novel Gene,PSD,Adjacent toNFKB2/lyt-10,Which Contains Sec7 and Pleckstrin-Homology Domains (Q24317209) (← links)
- 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) role in hematopoiesis and in hematologic diseases: A critical review. (Q30244256) (← links)
- Central venous catheter-related complications in patients with hematological malignancies: a retrospective analysis of risk factors and prophylactic measures. (Q33357198) (← links)
- Acute myeloid leukemia and pregnancy: clinical experience from a single center and a review of the literature (Q33827589) (← links)
- Severe fludarabine neurotoxicity after reduced intensity conditioning regimen to allogeneic hematopoietic stem cell transplantation: a case report (Q35924914) (← links)
- BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci (Q36322298) (← links)
- Autologous mesenchymal stem cell therapy for progressive supranuclear palsy: translation into a phase I controlled, randomized clinical study (Q37550552) (← links)
- The European Consensus on grading of bone marrow fibrosis allows a better prognostication of patients with primary myelofibrosis. (Q38013039) (← links)
- Dioxin exposure of human CD34 hemopoietic cells induces gene expression modulation that recapitulates its in vivo clinical and biological effects (Q38337517) (← links)
- Changes in the incidence of candidemia and related mortality in patients with hematologic malignancies in the last ten years. A SEIFEM 2015-B report (Q40125779) (← links)
- An unusual type of myeloid sarcoma localization following myelofibrosis: A case report and literature review. (Q41189441) (← links)
- The involvement of the candidate proto-oncogene NFKB2/lyt-10 in lymphoid malignancies. (Q41342055) (← links)
- Mesenchymal Stem Cells in Myeloid Malignancies: A Focus on Immune Escaping and Therapeutic Implications. (Q41695046) (← links)
- p53 protein expression in laryngeal squamous cell carcinomas bearing wild-type and mutated p53 gene. (Q42523090) (← links)
- EHT, a new member of the MTG8/ETO gene family, maps on 20q11 region and is deleted in acute myeloid leukemias. (Q42684876) (← links)
- Biological and molecular characterization of PNH-like lymphocytes emerging after Campath-1H therapy. (Q43572271) (← links)
- Hyperhomocysteinemia in myelodysplastic syndromes: specific association with autoimmunity and cardiovascular disease. (Q43600770) (← links)
- High levels of vascular endothelial growth factor protein expression are associated with an increased risk of transfusion dependence in myelodysplastic syndromes. (Q44509186) (← links)
- Posttransplantation cutaneous B-cell lymphoma with monoclonal Epstein-Barr virus infection, responding to acyclovir and reduction in immunosuppression. (Q45760236) (← links)
- Bone marrow glycophorin-positive erythroid cells of myelodysplastic patients responding to high-dose rHuEPO therapy have a different gene expression pattern from those of nonresponders. (Q46668770) (← links)
- A long-term follow-up analysis in adult acute myeloid leukemia patients after hematopoietic stem cell transplantation. (Q46929126) (← links)
- SEIFEM 2017: from real life to an agreement on the use of granulocyte transfusions and colony-stimulating factors for prophylaxis and treatment of infectious complications in patients with hematologic malignant disorders. (Q47235713) (← links)
- Clinical management of peripherally inserted central catheters compared to conventional central venous catheters in patients with hematological malignancies: A large multicenter study of the REL GROUP (Rete Ematologica Lombarda - Lombardy Hematologi (Q47691708) (← links)
- p53 and cyclin D1 protein expression in glottic laryngeal squamous cell carcinomas involving the anterior commissure (pT1bN0M0) (Q47763339) (← links)
- Secondary acute myeloid leukaemia in elderly patients: Patient's fitness criteria and ELN prognostic stratification can be applied to guide treatment decisions. An analysis of 280 patients by the network rete ematologica lombarda (REL). (Q48256316) (← links)
- FarmaREL: An Italian pharmacovigilance project to monitor and evaluate adverse drug reactions in haematologic patients (Q48297666) (← links)
- Clonal reticulohistiocytosis of the skin and bone marrow associated with systemic mastocytosis and acute myeloid leukaemia (Q48365299) (← links)
- Severe hypofibrinogenemia associated with imatinib and prednisone therapy in Philadelphia chromosome-positive acute lymphoblastic leukemia (Q49561637) (← links)
- Concomitant Occurrence of Blastic Plasmacytoid Dendritic Cell Neoplasm and Acute Myeloid Leukaemia after Lenalidomide Treatment for. (Q50209465) (← links)
- FGFR3 gene mutations associated with human skeletal disorders occur rarely in multiple myeloma (Q52183589) (← links)
- PDGFB hypomethylation is a favourable prognostic biomarker in primary myelofibrosis. (Q53079774) (← links)
- An acquired factor VIII inhibitor in a myeloproliferative neoplasm presenting with severe retroperitoneal hemorrhage. (Q53167725) (← links)
- Survivin expression in "low-risk" and "high-risk" myelodysplastic syndromes. (Q53246293) (← links)
- Poor prognosis in non-villous splenic marginal zone cell lymphoma is associated with p53 mutations. (Q53438743) (← links)
- Increased expression of vascular endothelial growth factor receptor 1 correlates with VEGF and microvessel density in Philadelphia chromosome-negative myeloproliferative neoplasms. (Q54621350) (← links)
- The prevalence and clinical relevance of p27 and cyclin E immunoreactivity in myelodysplastic syndromes (Q56779676) (← links)
- Invasive fungal sinusitis: An effective combined treatment in five haematological patients (Q58376545) (← links)
- Successful Treatment With Imatinib in a Patient With Chronic Eosinophilic Leukemia Not Otherwise Specified (Q59538736) (← links)
- FISH characterization of t(8;12)(q12;p13) observed as the sole karyotypic anomaly in a myelodysplastic syndrome patient (Q61854450) (← links)
- Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis (Q62395188) (← links)
- p53 tumour suppressor gene and RAS oncogenes: molecular analysis in the chronic and leukaemic phases of essential thrombocythaemia (Q71127553) (← links)
- Molecular analysis of cutaneous B- and T-cell lymphomas (Q71789578) (← links)
- bcl-1, bcl-2, p53, c-myc, and lyt-10 analysis in cutaneous lymphomas (Q71836653) (← links)
- Frequent p53 gene involvement in splenic B-cell leukemia/lymphomas of possible marginal zone origin (Q72032259) (← links)
- Uncommon clinical presentation of a lymphocytic lymphoma of intermediate differentiation in a patient with systemic sclerosis (Q72089400) (← links)
- Multiple genetic lesions in laryngeal squamous cell carcinomas (Q72610855) (← links)
- Analysis of p53 and ras gene mutations in endometriosis (Q72801874) (← links)
- Structural alterations of the NF-kappa B transcription factor lyt-10 in lymphoid malignancies (Q72935584) (← links)
- Molecular and immunohistochemical analysis of the bcl-1/cyclin D1 gene in laryngeal squamous cell carcinomas: correlation of protein expression with lymph node metastases and advanced clinical stage (Q73155419) (← links)
- Bcl-2 protein expression and p53 gene mutation in chronic lymphocytic leukemia: correlation with in vitro sensitivity to chlorambucil and purine analogs (Q73232839) (← links)